Product Introduction
Our high-quality Pacific Blue Mouse Anti-Human CD1a Antibody (S-R527A) is expertly engineered for the specific and sensitive detection of human CD1a in life science research applications. This antibody offers outstanding consistency and performance, making it an indispensable tool for immunology and cell biology studies. To access the full product details, please visit: https://en.starter-bio.com/s0b8280_pacific_blue_mouse_anti_human_cd1a_antibody_s_r527a.html
Brand
ANTBIO - a trusted brand in the life science industry, renowned for producing high-performance, rigorously quality-tested antibodies and research reagents for global researchers.
Product Performance Parameters
• Target: Human CD1a (Cluster of Differentiation 1a)
• Conjugate: Pacific Blue
• Host Species: Mouse
• Clone: S-R527A
• Applications: Flow Cytometry (FCM), Immunofluorescence (IF), Immunohistochemistry (IHC)
• Specificity: Exceptional specificity to human CD1a, no cross-reactivity with other CD1 family members
• Purity: ≥98% (Purified by Protein G affinity chromatography)
• Formulation: Liquid in PBS buffer (pH 7.4) with 0.02% sodium azide and 0.5% BSA
• Storage Conditions: 2-8°C for short-term storage (up to 6 months); -20°C for long-term storage (avoid repeated freeze-thaw cycles)
• Shelf Life: 24 months from manufacturing date (when stored as recommended)
• Validation: Fully validated in human peripheral blood cells, dendritic cell samples and tissue sections
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Singapore
